Intrathecal nicorandil and small-dose morphine can induce spastic paraparesis after a noninjurious interval of spinal cord ischemia in the rat

Anesthesia and Analgesia

Volumn 102, Issue 4, 2006, Pages 1217-1222

  Fuchigami, Tatsuya ^b   Kakinohana, Manabu ^a   Nakamura, Seiya ^b   Murata, Kenji ^b   Sugahara, Kazuhiro ^b  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; MORPHINE; NICORANDIL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; LOW DRUG DOSE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REPERFUSION; SPASTIC PARAPLEGIA; SPINAL CORD ISCHEMIA;

EID: 33645508368     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000198634.25504.83     Document Type: Article

References (32)

1. Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth 1995;42:891-903.
2. Kofke WA, Garman RH, Garman R, et al. Opioid neurotoxicdity: fentanyl-induced exacerbation of cerebral ischemia in rats. Brain Res 1999;818:326-34.
3. Kakinohana M, Marsala M, Carter C, et al. Neuraxial morphine may trigger transient spasticity after a non-injurious interval of spinal cord ischemia: a clinical and experimental study. Anesthesiology 2003;98:862-70.
4. Kakinohana M, Fuchigami T, Nakamura S, et al. Intrathecal administration of morphine, but not low dose, induced spastic paraparesis after non-injurious interval of aortic occlusion in rat. Anesth Analg 2003;96:769-75.
5. Namakura S, Kakinohana M, Taira Y, et al. The effect of gamma-aminobutyric acid (GABA) receptor drugs on morphine-induced spastic paraparesis after a noninjurious interval of spinal cord ischemia in rats. Anesth Analg 2002;95:1389-95.
6. North RA. Drug receptors and the inhibition of nerve cells. Br J Pharmacol 1989;98:13-28.
7. Ocana M, Pozo ED, Barrios M, et al. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 1990;186:377-8.
8. Narita M, Takahashi Y, Suzuki T, et al. An ATP-sensitive potassium channel blocker abolishes the potentiating effect of morphine on the bicuculline-induced convulsion in mice. Psychopharmacology 1993;110:500-2.
9. Yaksh TL, Rudy T. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976;17:1031-6.
10. Taira Y, Marsala M. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Stroke 1996;27:1850-8.
11. Zivin AJ, Wand DR. Quantal bioassay and stroke. Stroke 1992;23:767-73.
12. Yaksh TL. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesth Scan 1997;41:94-111.
13. Zieglgansberger W, French ED, Siggins GR. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 1979;205:415-7.
14. Cohen GA, Doze VA, Madison DV. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron 1992;9:325-35.
15. Wilcox GL, Seybold V. Pharmacology of spinal afferent processing. In: Yaksh TL, Lynch C III, Zapol, WM, et al., eds. Anaesthesia: biologic foundations. Philadelphia: Lippincott-Raven, 1997;557-76.
16. Felpel LP, Sinclair JG, Yim GK. Effects of morphine on Renshaw cell activity. Neuropharmacology 1970;9:203-10.
17. Frenk H, Watkins LR, Mayer DJ. Differential behavioral effects induced by intrathecal microinjection of opiates: comparison of convulsive and cataleptic effects produced by morphine, methadone, and D-Ala2-methionine-enkephalinamide. Brain Res 1984;299:31-42.
18. Shohami E, Evron S. Intrathecal morphine induces myoclonic seizures in the rat. Acta Pharmacol Toxicol 1985;56:50-4.
19. Yaksh TL, Harty GJ. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J Pharmacol Exp Ther 1988;244:501-7.
20. Ting P, Xu S, Krumins S. Endogenous opioid system activity following temporary focal cerebral ischemia. Acta Neurochir 1994;60(Suppl):253-6.
21. Ashcroft FM. Adenosine 5′-triphosphate-sensitive potassium channels. Ann Rev Neurosci 1990;247:852-4.
22. Narita M, Suzuki T, Misawa M, et al. Role of central ATP-sensitive potassium channels in the analgesic effect and spinal noradrenaline turnover-enhancing effect of intracerebroventricularly injected morphine in mice. Brain Res 1992;596:209-14.
23. Ocana M, Pozo ED, Barrios M, et al. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 1990;186:377-8.
24. + channels are involved in the mediation of intrathecal norepinephrine- or morphine-induced antinociception at the spinal level: a study using EMG planimetry of flex reflex in rats. Brain Res Bull 1998;45:269-73.
25. Vergoni AV, Scarano A, Bertolini A. Pinacidil potentiates morphine analgesia. Life Sci 1992;50:PL135-8.
26. + channel-acting drugs. Br J Pharmacol 1995;114:1296-302.
27. Ocana M, Del PE, Baeyens JM. Cromakalim differentially enhances antinociception induced by agonists of alpha 2 adrenoceptors, γ-aminobutyric acid, mu and kappa opioid receptors. J Pharmacol Exp Ther 1996;276:1136-42.
28. Welch SP, Dunlow LD. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J Pharmacol Exp Ther 1993;267:390-9.
29. + channel blockers antagonize morphine- but not U-50,488H-induced antinociception. Eur J Pharmacol 1993;230:203-7.
30. Kang YM, Hu WM, Qiao JT. Endogenous opioids and ATP-sensitive potassium channels are involved in the mediation of apomorphine-induced antinociception at the spinal level: a behavioral study in rats. Brain Res Bull 1998;46:225-8.
31. + channels. Pflugers Arch 1990;415:479-83.
32. Grundt TJ, Williams JT. A μ-opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat. J Neurosci 1994;14(3 pt 2):1646-54.